(Q34440991)

2 August 2017

1 reference

title

Factors modifying the migration of lymphocytes across the blood-brain barrier (English)

1 reference

2 August 2017

1 reference

Brown KA

1

1 reference

2 August 2017

1 November 2001

1 reference

International Immunopharmacology

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

12

1 reference

2 August 2017

2043-2062

1 reference

Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

T-lymphocyte entry into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Immunopathogenesis of multiple sclerosis: the role of T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Progress in determining the causes and treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Ubiquitous pathogens: links between infection and autoimmunity in MS?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Pathogenesis of tissue injury in MS lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Multiple sclerosis: a pivotal role for the T cell in lesion development

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Clinical trials of interferons in multiple sclerosis. What have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

1 reference

7 January 2021

Increased numbers of mononuclear cells from blood and CSF expressing interferon-gamma mRNA in multiple sclerosis are from both the CD4+ and the CD8+ subsets

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Multiple Sclerosis: Limited Diversity of the V?2-J?3 T-Cell Receptor in Chronic Active Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

T cell receptor gamma delta repertoire is skewed in cerebrospinal fluid of multiple sclerosis patients: molecular and functional analyses of antigen-reactive gamma delta clones

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Evidence for a role of gammadelta T cells in demyelinating diseases as determined by activation states and responses to lipid antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Endothelial-leukocyte adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

The role of integrins in immune-mediated diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Chemokines and the arrest of lymphocytes rolling under flow conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Relapsing autoimmune demyelination: a role for vascular addressins

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Short-lived immunization site inflammation in self-limited active experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Regulated expression and binding of three VLA (beta 1) integrin receptors on T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

T-cell memory: the connection between function, phenotype and migration pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Selective localisation of neuro-specific T lymphocytes in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Enhanced binding of lymphocytes from patients with multiple sclerosis to tumour necrosis factor-alpha (TNF-alpha)-treated endothelial monolayers: associations with clinical relapse and adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Lymphocyte-endothelial cell interactions in multiple sclerosis: disease specificity and relationship to circulating tumour necrosis factor-alpha and soluble adhesion molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Selective binding of peripheral blood lymphocytes to the walls of cerebral vessels in frozen sections of human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Adhesion of mononuclear cells from multiple sclerosis patients to cerebral vessels in cryostat sections of normal human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Evidence for a prolonged role of alpha 4 integrin throughout active experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Phenotyping analysis of peripheral blood leukocytes in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Inhibition of experimental allergic encephalomyelitis with an antibody that recognizes a novel antigen expressed on lymphocytes, endothelial cells, and microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Soluble and cell surface ICAM-1 as markers for disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Lymphocyte interactions with endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Regulation of the VLA integrin-ligand interactions through the beta 1 subunit

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Shedding of TNF receptors in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Cytokines and soluble IL-4 in patients with acute optic neuritis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Antigen-specific T cell trafficking into the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Astrocytes present myelin basic protein to encephalitogenic T-cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Human brain microvascular DR-antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Major histocompatibility complex class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

On the immunopathology of plaque development and repair in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Identification of cell types producing RANTES, MIP-1 alpha and MIP-1 beta in rat experimental autoimmune encephalomyelitis by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

The matrix-degrading metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Matrix metalloproteinases degrade myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Structural biochemistry and activation of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Lymphocyte migration and multiple sclerosis: relation with disease course and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Expression of the beta-chemokines RANTES and MIP-1 beta by human brain microvessel endothelial cells in primary culture

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Local neurochemicals and site-specific immune regulation in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Intracerebral injection of proinflammatory cytokines or leukocyte chemotaxins induces minimal myelomonocytic cell recruitment to the parenchyma of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2801%2900129-1

7 January 2021

10.1016/S1567-5769(01)00129-1

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11710535